Amarin Corporation
AMRN
#7762
Rank
$0.34 B
Marketcap
$16.54
Share price
0.49%
Change (1 day)
65.40%
Change (1 year)

Revenue for Amarin Corporation (AMRN)

Revenue in 2025 (TTM): $0.22 Billion USD

According to Amarin Corporation 's latest financial reports the company's current revenue (TTM ) is $0.22 Billion USD. In 2024 the company made a revenue of $0.22 Billion USD a decrease over the revenue in the year 2023 that were of $0.30 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amarin Corporation from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $0.22 B-0.82%
2024 $0.22 B-25.51%
2023 $0.30 B-16.87%
2022 $0.36 B-36.69%
2021 $0.58 B-5.03%
2020 $0.61 B42.89%
2019 $0.42 B87.49%
2018 $0.22 B26.57%
2017 $0.18 B39.22%
2016 $0.13 B59.11%
2015 $81.75 M50.84%
2014 $54.2 M105.7%
2013 $26.35 M
2012 N/A
2011 N/A
2010 N/A
2003 -$15.03 Million-122.94%
2002 $65.5 M21.82%
2001 $53.77 M203.19%
2000 $17.73 M
1998 $18.9 M-20.92%
1997 $23.9 M5.29%
1996 $22.7 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AbbVie
ABBV
$59.64 B 26,205.72%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$58.12 B 25,536.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alkermes
ALKS
$1.52 B 570.98%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
GlaxoSmithKline
GSK
$42.35 B 18,579.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$16.77 B 7,298.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel